Authors: KEREIAKES DJ FERGUSON JJ MASUD AZ KLEIMAN NS ABBOTTSMITH CW ANDERS RJ HANTSBARGER GL KOWALSKI KG DREILING RJ

Citation: Dj. Kereiakes et al., SUSTAINED PLATELET GP IIB IIIA BLOCKADE WITH ORAL XEMILOFIBAN - FINALRESULTS OF THE ORBIT TRIAL/, Circulation, 96(8), 1997, pp. 2158-2158

Authors: KOWALSKI KG KARIM A

Citation: Kg. Kowalski et A. Karim, A SEMICOMPARTMENTAL MODELING APPROACH FOR PHARMACODYNAMIC DATA ASSESSMENT, Journal of pharmacokinetics and biopharmaceutics, 23(3), 1995, pp. 307-322

Authors: FISCHL MA RESNICK L COOMBS R KREMER AB POTTAGE JC FASS SJ FIFE KH POWDERLY WG COLLIER AC ASPINALL RL SMITH SL KOWALSKI KG WALLEMARK CB

Citation: Ma. Fischl et al., THE SAFETY AND EFFICACY OF COMBINATION N-BUTYL-DEOXYNOJIRIMYCIN (SC-48334) AND ZIDOVUDINE IN PATIENTS WITH HIV-1 INFECTION AND 200-500 CD4 CELLS MM(3)/, Journal of acquired immune deficiency syndromes, 7(2), 1994, pp. 139-147

Authors: KOWALSKI KG

Citation: Kg. Kowalski, AN ALGORITHM FOR ESTIMATING THE TERMINAL HALF-LIFE IN PHARMACOKINETICSTUDIES, Computer methods and programs in biomedicine, 42(2), 1994, pp. 119-126

Authors: COOK CS AMES GB SMITH ME KOWALSKI KG KARIM A

Citation: Cs. Cook et al., ABSORPTION AND DISPOSITION OF A NEW ANTIARRHYTHMIC AGENT BIDISOMIDE IN MAN, Pharmaceutical research, 10(11), 1993, pp. 1675-1682